RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity

Human Molecular Genetics

Volumn 15, Issue 18, 2006, Pages 2804-2812

  Lipska, Barbara K ^a   Mitkus, Shruti ^a   Caruso, Mark ^a   Hyde, Thomas M ^a   Chen, Jingshan ^a   Vakkalanka, Radhakrishna ^a   Straub, Richard E ^a   Weinberger, Daniel R ^a   Kleinman, Joel E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; METHIONINE; RGS PROTEIN; RGS4 PROTEIN; UNCLASSIFIED DRUG; VALINE;

ALLELE; ANIMAL TISSUE; ARTICLE; AUTOPSY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EPISTASIS; GENE EXPRESSION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MENTAL PATIENT; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AMINO ACID SUBSTITUTION; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; GENE EXPRESSION; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RGS PROTEINS; RNA, MESSENGER; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 33748744944     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl222     Document Type: Article

References (41)

1. Talkowski, M.E., Seltman, H., Basset, A.S., Brzustowicz, L.M., Chen, X., Chowdari, K.V., Collier, D.A., Cordeiro, Q., Corvin, A.P., Deshpande, S. et al. (2006) Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from 13 independent samples. Biol. Psychiatry, 60, 152-162.
2. Mirnics, K., Middleton, F.A., Stanwood, G.D., Lewis, D.A. and Levitt, P. (2001) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry, 6, 293-301.
3. Chowdari, K.V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., Deshpande, S.N., Ferrell, R.E., Middleton, F.A., Devlin, B. et al. (2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet., 11, 1373-1380.
4. Chen, X., Dunham, C., Kendler, S., Wang, X., O'Neill, F.A., Walsh, D. and Kendler, K. S. (2004) Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am. J. Med. Genet. B Neuropsychiatr. Genet., 129, 23-26.
5. Morris, D.W., Rodgers, A., McGhee, K.A., Schwaige, R.S., Scully, P., Quinn, J., Meagher, D., Waddington, J.L., Gill, M. and Corvin, A.P. (2004) Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet., 125, 50-53.
6. Williams, N.M., Preece, A., Spurlock, G., Norton, N., Williams, H.J., McCreadie, R.G., Buckland, P., Sharkey, V., Chowdari, K.V., Zammit, S. et al. (2004) Support for RGS4 as a susceptibility gene for schizophrenia. Biol. Psychiatry, 55, 192-195.
7. Zhang, F., St Clair, D., Liu, X., Sun, X., Sham, P.C., Crombie, C., Ma, X., Wang, Q., Meng, H., Deng, W. et al. (2005) Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia. Genes Brain Behav., 4, 444-448.
8. Cordeiro, Q., Talkowski, M.E., Chowdari, K.V., Wood, J., Nimgaonkar, V. and Vallada, H. (2005) Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav., 4, 45-50.
9. Sobell, J.L., Richard, C., Wirshing, D.A. and Heston, L.L. (2005) Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am. J. Med. Genet. B Neuropsychiatr. Genet., 139, 23-27.
10. Prasad, K.M., Chowdari, K.V., Nimgaonkar, V.L., Talkowski, M.E., Lewis, D.A. and Keshavan, M.S. (2005) Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol. Psychiatry, 10, 213-219.
11. Geurts, M., Hermans, E. and Maloteaux, J.M. (2002) Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum. Neurosci. Lett., 333, 146-150.
12. Schwendt, M., Gold, S.J. and McGinty, J.F. (2006) Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D and D dopamine receptors. J. Neurochem., 96, 1606-1615.
13. Taymans, J.M., Leysen, J.E. and Langlois, X. (2003) Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: Clues for RGS2 and RGS4 functions. J. Neurochem., 84, 1118-1127.
14. Erdely, H.A., Lahti, RA., Lopez, M.B., Myers, C.S., Roberts, R.C., Tamminga, C.A. and Vogel, M.W. (2004) Regional expression of RGS4 mRNA in human brain. Eur. J. Neurosci., 19, 3125-3128.
15. Tunbridge, E.M., Harrison, P.J. and Weinberger, D.R. (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val(158)Met and beyond. Biol. Psychiatry, 60, 141-151.
16. Nicodemus, K.K., Kolachana, B.S., Vakkalanka, R., Straub, R.E., Giegling, I., Egan, M.F., Rujescu, D. and Weinberger, D.R. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) polymorphisms in RGS4 G72 (DAOA) GRM3 DISC1: Influence on risk of schizophrenia. Hum Mol Gen. In press.
17. Chen, J., Lipska, B.K., Halim, N., Ma, Q.D., Matsumoto, M., Melhem, S., Kolachana, B.S., Hyde, T.M., Herman, M.M., Apud, J. et al. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet., 75, 807-821.
18. Erdely, H.A., Tamminga, C.A., Roberts, R.C. and Vogel, M.W. (2006) Regional alterations in RGS4 protein in schizophrenia. Synapse, 59, 472-479.
19. McKinley, S.M. (1977) Pair-matching - a reappraisal of a popular technique. Biometrics, 33, 725-735.
20. Breslow, N. (1982) Design and analysis of case-control studies. Ann. Rev. Public Health, 3, 9-54.
21. Krumin, A.M., Barker, S.A., Huang, C., Sunahara, R.K., Yu, K., Wilkie, T.M., Gold, S.J. and Mumby, S.M. (2004) Differentially regulated expression of endogenous RGS4 and RGS7. J. Biol. Chem., 279, 2593-2599.
22. Karoum, F., Chrapusta, S.J. and Egan, M.F. (1994) 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem., 63, 972-979.
23. Gogos, J.A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D. and Karayiorgou, M. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl Acad. Sci. USA, 95, 9991-9996.
24. Ceravolo, R., Piccini, P., Bailey, D.L., Jorga, K.M., Bryson, H. and Brooks, D.J. (2202) 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease. Synapse, 43, 201-207.
25. Tunbridge, E.M., Bannerman, D.M., Sharp, T. and Harrison, P.J. (2004) Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci., 24, 5331-5335.
26. Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Mazzanti, C.M., Straub, R.E., Goldman, D. and Weinberger, D.R. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA, 98, 6917-6922.
27. Mattay, V.S., Goldberg, T.E., Fera, F., Hariri, A.R., Tessitore, A., Egan, M.F., Kolachana, B., Callicott, J.H. and Weinberger, D.R. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl Acad. Sci. USA, 100, 6186-6191.
28. Akil, M., Kolachana, B.S., Rothmond, D.A., Hyde, T.M., Weinberger, D.R. and Kleinman, J.E. (2003) Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J. Neurosci., 23, 2008-2013.
29. Meyer-Lindenberg, A., Kohn, P.D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D.R. and Berman, K.F. (2005) Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat. Neurosci., 8, 594-596.
30. Taymans, J.M., Kia, H.K., Claes, R., Cruz, C., Leysen, J. and Langlois, X. (2004) Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. Eur. J. Neurosci., 19, 2249-2260.
31. Yuferov, V., Kroslak, T., Laforge, K.S., Zhou, Y., Ho, A. and Kreek, M.J. (2003) Differential gene expression in the rat caudate putamen after 'binge' cocaine administration: Advantage of triplicate microarray analysis. Synapse, 48, 157-169.
32. Bishop, G.B., Cullinan, W.E., Curran, E. and Gutstein, H.B. (2002) Abused drugs modulate RGS4 mRNA levels in rat brain: Comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis., 10, 334-343.
33. Burchett, S.A., Bannon, M.J. and Granneman, J.G. (1999) RGS mRNA expression in rat striatum: Modulation by dopamine receptors and effects of repeated amphetamine administration. J. Neurochem., 72, 1529-1533.
34. Parlaman, J.P., Stanwood, G.D. and Levitt, P. (2005) Genetic inactivation of the dopamine D1 receptor induced altered expression of specific regulator of G-protein-signaling (RGS) transcripts. Program No. 1032.12, 2005 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC, 2005. Online.
35. Grillet, N., Pattyn, A., Contet, C., Kieffer, B.L., Goridis, C. and Brunet, J.F. (2005) Generation and characterization of Rgs4 mutant mice. Mol. Cell. Biol., 25, 4221-4228.
36. Ding, J., Guzman, J.N., Tkatch, T., Chen, S., Goldberg, J.A., Ebert, P.J., Levitt, P., Wilson, C.J., Hamm, H.E. and Surmeier, D.J. (2006) RGS4-dependent attenuation of M(4) autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat. Neurosci., 9, 832-842.
37. Matsumoto, M., Weickert, C.S., Akil, M., Lipska, B.K., Hyde, T.M., Herman, M.M., Kleinman, J.E. and Weinberger, D.R. (2003) Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function. Neuroscience, 116, 127-137.
38. Lipska, B.K., Peters, T., Halim, N., Mitkus, S., Shannon Weickert, C., Matsumoto, M., Sawa, A., Hyde, T.M., Weinberger, D.R. and Kleinman, J.E. (2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet., 15, 1245-1258.
39. Caspi, A., Moffitt, T.E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R. and Craig, I.W. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol. Psychiatry, 57, 1117-1127.
40. Lipska, B.K., Deep-Soboslay, A., Shannon Weickert, C., Hyde, T.M., Martin, C.E., Herman, M.M. and Kleinman, J.M. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol. Psychiatry. In press.
41. Livak, K.J. (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal., 14, 143-149.